Enteral Feeding Devices – Lifeline for Cancer Patients
The global market for enteral feeding devices is projected to grow at a compound annual growth rate of 4.26%. Over the forecast period, this market is estimated to increase at a rapid pace and is anticipated to reach US$2,320.075 million in 2027 from US$ 1,733.074 million in 2020.
Enteral feeding devices are medical equipment that feeds a patient via the gastrointestinal tract. Patients who have a functional GI tract but are unable to ingest or absorb enough food to maintain appropriate nutrition and hydration are given enteral feeding devices. They are also used when an individual’s physical limitations prevent them from eating, if his caloric needs have gone beyond what he can consume or if the patient cannot ingest food safely. Enteral feeding devices are extremely essential in the healthcare industry and therefore have a huge demand for them. The global market for enteral feeding devices is categorised into various segments which include – the type of device, the age group of the patient, the application, the end-user customer and the geographical region.
Rising incidences of chronic diseases such as cancer will foster growth for the global enteral feeding devices market during the analysis period.
It’s crucial to maintain a healthy diet when receiving treatment for chronic diseases such as stomach or gastric cancer, tumours, or autoimmune diseases such as diabetes. Therefore enteral feeding devices are their solution to get adequate nutrition. These medical devices inserted into the stomach or gastrointestinal tract can assist the supply of minerals, fluids, calories and vitamins required to support the body’s ability to recover, fight infections, and maintain health through the treatment process.
As a result, growing incidences of chronic disease cases among the population are one of the primary factors driving the demand for enteral feeding devices worldwide. Statistics provided by the American Cancer Society show that there will be around 26,380 new instances of stomach cancer and over 11,090 fatalities from the disease in 2022. According to the organisation’s data, 1.5 per cent of all new cancer cases diagnosed in the US each year are gastric cancer cases. Irritable bowel syndrome affects 10 to 15 per cent of people globally, according to a 2022 update by the International Foundation for Gastrointestinal Disorders. In the United Kingdom, 1 in every 123 people has ulcerative colitis or Crohn’s disease, according to a study done in 2022 by Crohn’s & Colitis UK. This translates to a total of close to 500,000 people with irritable bowel syndrome across the nation.
According to the research and analysis that have been done of the market, the demand for enteral feeding devices for diabetic patients is on the rise, during the anticipated period.
Based on the type of application, the enteral feeding devices market is categorized into gastroenterology patients, neurological patients, oncology patients, hypermetabolism, diabetic patients and people suffering from another type of disease or injury. Out of all these mentioned above diabetic patients are anticipated to account for a major share of the global market during the analysis period.
Enteral feeding is a process of giving adequate nutrition and feeding to patients via the gastrointestinal tract. There are devices available in the market that are used for this purpose. Doctors and medical professionals can control the amount of caloric content, sugars, glucose and starch (which increases the blood sugar level) going into the patient via this process. Diabetes patients may not experience overly high blood glucose levels, therefore this therapy is crucial for them.
The growing cases of diabetes among people are augmenting the growth of this segment during the forecast period. The data by IDF Atlas shows that, In 2021, 537 million individuals or 1 in 10 individuals had diabetes. By 2030, 643 million people will be living in this country, and by 2045, 783 million people. In 2021, diabetes was a factor in 6.7 million fatalities. Type 1 diabetes affects more than 1.2 million children and teenagers. Diabetes was the cause of at least US$966 billion in medical costs in 2021. World Health Organisation says that age-specific diabetes mortality rates increased by 3 per cent between 2000 and 2019.
By supplying the essential macro- and micronutrients, enteral nutrition plays a significant role in lowering the risk of malnutrition, maintaining blood sugar levels at safe levels and controlling symptoms in diabetes patients. Therefore, the community of diabetes patients is projected to see an increase in enteral feeding device demand in the coming years.
During the analysis period, the issues associated with the use of feeding devices are anticipated to obstruct the growth of the global enteral feeding devices market.
Even though enteral feeding devices are essential for a plethora of patients suffering from various diseases. However, the use of these devices has its fair share of side effects and complications. Enteral feeding can increase the risk of vomiting and aspiration, especially among children. Other negative physical effects include skin deterioration, diarrhoea, and anatomical disturbance. One mechanical drawback is a loose or blocked feeding tube. Hyperphosphatemia and hyperglycaemia are two metabolic concerns associated with enteral feeding.
The incidences of such incidents can be prevented by carefully monitoring these devices. Still, patients and their families are reluctant to use enteral feeding devices which are hindering the growth of the market globally.
During the analysis period, out of all the geographical regions the market is segmented into the North American region is likely to account for a rapid growth rate in the global enteral feeding devices market.
The global enteral feeding devices market has been divided into five regions: North America, South America, Europe, the Middle East and Africa, and Asia Pacific. During the projected period, the North American enteral feeding devices market is expected to grow significantly during the aforementioned period. Countries like the United States and Canada have well-established and quite advanced healthcare systems. The need for enteral feeding systems to meet the nutritional needs of those who cannot ingest food is anticipated to rise as the burden of chronic illnesses, the elderly population, and surgical operations increase in North America. According to the American Cancer Society, there will likely be roughly 26,500 new instances of gastric cancer in the US in 2023. 11.130 people lose their lives to this form of cancer. About 1.5 per cent of all new cancer cases identified in the US each year are gastric malignancies. The Terry Fox Research Institute specialising in cancer research in Canada says that, in Canada, gastric cancer is anticipated to affect 4,100 persons in 2022. This cancer is more common in adults over 50 and tends to afflict males more than women. Increased government spending on healthcare and more awareness of technological advancements are seen as key drivers of the enteral feeding devices market’s growth in North America. Prime markets in the North American region include Canada, the United States and Mexico.
